DNA SEQ
La Jolla, California, United States · Founded 2013
About DNA SEQ
DNA SEQ provides reports that match the patient's genomic profile to targeted therapies using unique crystallography based filtering methodology. Unique technology alliance that has developed a machine learning algorithm based on structural genomics leveraging crystallography and our proprietary crystal structures library, to match genomics of cancer patients with available targeted oncology drugs. Our predictive personalized medicine approach helps physicians make treatment decisions for cancer patients by identifying the molecular growth drivers of the cancer, and matching them to relevant targeted therapeutic options. NGS of the entire exome verse just panels because each patient’s resistance is different. Research reports that help physicians make treatment decisions for cancer patients by identifying the molecular growth drivers of the cancer, and matching them to relevant targeted therapeutic options.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Seed (May 2013)
- Website: http://www.dna-seqalliance.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Health Care
Canonical: https://fsome.com/organization/dna-seq-2542898 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.